Company Overview of Oryzon Genomics S.A.
Oryzon Genomics S.A., a biopharmaceutical company, develops and commercializes biomarkers identified through genomics and proteomics in the fields of diagnostics, personalized medicine, and therapy. Its products pipeline comprises GynEC-DX, a diagnostic test for endometrial cancer; ColoBRAF, a genetic test that verifies the presence of the BRAF-V600E mutation in MSI-H tumors; and Cxbladder, a non-invasive bladder cancer diagnostic test. The company also develops small molecules and monoclonal antibodies for various indications, including leukemia and other cancers, PD/AD and other dementias, Huntington, viral infections, squamous cell cancer, prostate cancer, and endometrial cancer. In addit...
Sant Ferran 74
Cornellà de Llobregat
Founded in 2000
Key Executives for Oryzon Genomics S.A.
Global Chief Financial Officer
Chief Intellectual Property Officer
Director of Business Development
Compensation as of Fiscal Year 2014.
Oryzon Genomics S.A. Key Developments
Oryzon Genomics SA Appoints Greg Weaver as Executive Vice President and Global Chief Financial Officer
Jan 12 15
Oryzon Genomics SA announced the appointment of Gregory L. Weaver as executive vice president and chief financial officer, effective January 12, 2015. Weaver will report directly to Carlos Buesa, president and chief executive officer of Oryzon, and will be based at Oryzon's U.S. headquarters, located at 245 First Street in Cambridge, MA. Weaver has served as CFO Fibrocell Science. Previous to Fibrocell, Weaver was CFO at Celsion Corp, Poniard Pharmaceuticals and Sirna Therapeutics. He also currently serves as non-executive director of Egalet Corporation and Atossa Genetics. Oryzon's Mr. Enric Rello will remain as CFO in Spain and will continue as part of Oryzon's senior management team to support the company's financial operations in Spain.
Oryzon Genomics S.A. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 10:45 AM
Dec 24 14
Oryzon Genomics S.A. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 10:45 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Oryzon Genomics S.A. Presents at EPIC Biotech 2014, Oct-02-2014 04:00 PM
Sep 24 14
Oryzon Genomics S.A. Presents at EPIC Biotech 2014, Oct-02-2014 04:00 PM. Venue: The King's Fund, 11-13 Cavendish Square, London, W1G 0AN, United Kingdom.
Similar Private Companies By Industry
Recent Private Companies Transactions